Article info
PDFEditorial
Donor intravascular monocyte trafficking: a potential therapeutic target for primary graft dysfunction following lung transplantation?
- Correspondence to Dr Christopher Andrew Lamb, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; christopher.lamb{at}newcastle.ac.uk
Citation
Donor intravascular monocyte trafficking: a potential therapeutic target for primary graft dysfunction following lung transplantation?
Publication history
- First published January 31, 2018.
Online issue publication
September 01, 2022
Article Versions
- Previous version (20 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.